Isamu Mizote
Overview
Explore the profile of Isamu Mizote including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okamoto N, Mizote I, Ishihara T, Nakamura D, Shiraki T, Itaya N, et al.
Catheter Cardiovasc Interv
. 2025 Feb;
PMID: 39898422
Background: The changes over time and effects on long-term clinical outcomes beyond 1 year of irregular protrusion (IP) in chronic coronary syndrome (CCS) remains unclear. Aims: This study aimed to...
2.
Nakamura D, Mizote I, Ishihara T, Matsuhiro Y, Okuno S, Shiraki T, et al.
Am J Cardiol
. 2025 Jan;
PMID: 39863239
A dual-therapy sirolimus-eluting and CD34+ antibody-coated Combo Stent (DTS) has been developed to enhance endothelization and capture endothelial progenitor cells; however, vessel responses following DTS implantation remain unclear. Therefore, we...
3.
Matsuhiro Y, Mizote I, Nakamura D, Dohi T, Maeda K, Shimamura K, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
PMID: 39831761
Background: The long-term valve durability of supra-annular self-expanding valves (SEV) and intra-annular balloon-expandable valves (BEV) in patients with small aortic annuli remains unexplored. Aims: This study aimed to determine the...
4.
Mima H, Oka T, Sera F, Sekihara T, Ozu K, Akazawa Y, et al.
J Cardiol Cases
. 2024 Dec;
30(6):189-192.
PMID: 39697689
Learning Objectives: The appropriate selection of a cardiac implantable electronic device (CIED) in patients with adult congenital heart disease requires careful consideration. The pre-implantation feasibility test for combining a leadless...
5.
Furukawa T, Mizote I, Shiraki T, Nakamura D, Nishio M, Fukushima N, et al.
Intern Med
. 2024 Nov;
PMID: 39523004
Background Recent guidelines recommend dual antiplatelet therapy (DAPT) for six months following percutaneous coronary intervention (PCI) in patients with chronic coronary disease, as unexpected hospitalization can trigger DAPT discontinuation. This...
6.
Kawamura A, Shimamura K, Yoshioka D, Misumi Y, Yamashita K, Maeda K, et al.
JTCVS Tech
. 2024 Oct;
27:51-59.
PMID: 39478919
Background: When transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV) is considered as a secondary interventional option, it is desirable to estimate the risk of coronary obstruction during future TAV-in-SAV before the...
7.
Maeda K, Shimamura K, Mizote I, Nakamura D, Yamashita K, Kawamura A, et al.
Gen Thorac Cardiovasc Surg
. 2024 Oct;
PMID: 39441472
Objective: Transapical-transcatheter aortic valve replacement is one of the main interventions indicated for patients where access via peripheral vessels is challenging. However, there have been no reports on the long-term...
8.
A risk model of mortality rate in dialysis patients following transcatheter aortic valve replacement
Yamashita K, Maeda K, Pak K, Shimamura K, Kawamura A, Mizote I, et al.
J Cardiol
. 2024 Aug;
PMID: 39097143
Background: Dialysis patients undergoing transcatheter aortic valve replacement (TAVR) generally have poor prognosis compared with non-dialysis patients. Furthermore, there are few reliable risk models in this clinical setting. Therefore, we...
9.
Nishino M, Egami Y, Nohara H, Kawanami S, Ukita K, Kawamura A, et al.
Circ J
. 2024 Jul;
88(11):1758-1767.
PMID: 38987207
Background: Coronary angioscopy (CAS) has 2 unique abilities: direct visualization of thrombi and plaque color. However, in the recent drug-eluting stent (DES) era, serial CAS findings after DES implantation have...
10.
Kosugi S, Mizote I, Nakamura D, Miyagawa S, Sakata Y
Circ J
. 2024 May;
88(8):1343.
PMID: 38777766
No abstract available.